Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals Revenue

Crinetics Pharmaceuticals had revenue of $1.03M in the quarter ending June 30, 2025, with 158.40% growth. This brings the company's revenue in the last twelve months to $1.39M, up 0.51% year-over-year. In the year 2024, Crinetics Pharmaceuticals had annual revenue of $1.04M, down -74.11%.

• Revenue (ttm): $1.39M
• Revenue Growth: +0.51%
• P/S Ratio: 2,300.28
• Revenue / Employee: $3,185
• Employees: 437
• Market Cap: 3.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.04M	-2.97M	-74.11%
Dec 31, 2023	4.01M	-724.00K	-15.28%
Dec 31, 2022	4.74M	3.66M	339.42%
Dec 31, 2021	1.08M	1.01M	1,418.31%
Dec 31, 2020	71.00K	-1.12M	-94.05%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.